Links

Tools

Export citation

Search in Google Scholar

Phase 1b/2 trial of ribociclib+ binimetinib in metastatic NRAS-mutant melanoma: Safety, efficacy, and recommended phase 2 dose (RP2D).

Published in 2017 by Martin H. Schuler, Paolo A. Ascierto, Filip Yves Francine Leon De Vos, Michael Andrew Postow, Carla Ml Van Herpen, Matteo S. Carlino ORCID, Jeffrey A. Sosman, Carola Berking, Georgina Long, Amy Weise
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload